Predicting immunogenic tumour mutations by combining mass spectrometry and exome sequencing-Reference-Cited by-同舟云学术

Predicting immunogenic tumour mutations by combining mass spectrometry and exome sequencing

Published:2014-11-26 Issue:7528 Volume:515 Page:572-576
ISSN:0028-0836
Container-title:Nature
language:en
Short-container-title:Nature

Author:

Yadav Mahesh,Jhunjhunwala Suchit,Phung Qui T.,Lupardus Patrick,Tanguay Joshua,Bumbaca Stephanie,Franci Christian,Cheung Tommy K.,Fritsche Jens,Weinschenk Toni,Modrusan Zora,Mellman Ira,Lill Jennie R.,Delamarre Lélia

Publisher

Springer Science and Business Media LLC

Subject

Multidisciplinary

Link

http://www.nature.com/articles/nature14001.pdf

Reference38 articles.

1. Lawrence, M. S. et al. Mutational heterogeneity in cancer and the search for new cancer-associated genes. Nature 499, 214–218 (2013)

2. Matsushita, H. et al. Cancer exome analysis reveals a T-cell-dependent mechanism of cancer immunoediting. Nature 482, 400–404 (2012)

3. DuPage, M., Mazumdar, C., Schmidt, L. M., Cheung, A. F. & Jacks, T. Expression of tumour-specific antigens underlies cancer immunoediting. Nature 482, 405–409 (2012)

4. Castle, J. C. et al. Exploiting the mutanome for tumor vaccination. Cancer Res. 72, 1081–1091 (2012)

5. van Rooij, N. et al. Tumor exome analysis reveals neoantigen-specific T-cell reactivity in an ipilimumab-responsive melanoma. J. Clin. Oncol. 31, e439–e442 (2013)

Cited by 972 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. CO-DELIVERY of glutamic acid-extended peptide antigen and imidazoquinoline TLR7/8 agonist via ionizable lipid nanoparticles induces protective anti-tumor immunity;Biomaterials;2024-12

2. Enhancing Mass spectrometry-based tumor immunopeptide identification: machine learning filter leveraging HLA binding affinity, aliphatic index and retention time deviation;Computational and Structural Biotechnology Journal;2024-12

3. Recombinant ferritin-based nanoparticles as neoantigen carriers significantly inhibit tumor growth and metastasis;Journal of Nanobiotechnology;2024-09-14

4. Gemcitabine Resistant Triple Negative Breast Tumor Derived Mesoporous Silicon Nanovaccine Overcame Drug Resistance;Advanced Functional Materials;2024-09-13

5. Crucial Parameters for Immunopeptidome Characterization: A Systematic Evaluation;International Journal of Molecular Sciences;2024-09-03